Dominique Abell, APRN
Acute Care · Bardstown, KYNPI 1528148749
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (53.4%), food and beverage and education — rather than concentrated in one kind of arrangement. AbbVie accounts for 69.7% of it on its own, with 25 other manufacturers making up the rest. Reporting peaked in 2023 at $2,225 and has fallen 98.8% since, to $27 in 2024.
Across 64 payments — averaging $47.56 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$2K
- E.r. Squibb & Sons, L.L.C.$103
- Medical Device Business Services, Inc.$98
- Amgen$97
- Boehringer Ingelheim$48
- AstraZeneca$47
- plus $531 from 20 others
What the payments were for
- Travel & lodging$1,62653%
- Food & beverage$1,32043%
- Education$983%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 12 | $2,120 |
| E.r. Squibb & Sons, L.L.C. | 7 | $103 |
| Medical Device Business Services, Inc. | 1 | $98 |
| Amgen | 5 | $97 |
| Boehringer Ingelheim | 3 | $48 |
| AstraZeneca(2 entities) | 3 | $47 |
| Johnson & Johnson | 3 | $45 |
| Pfizer | 3 | $42 |
| Ipsen Biopharmaceuticals, Inc | 2 | $39 |
| Novartis | 2 | $38 |
| Acceleron Pharma, Inc. | 2 | $34 |
| Puma Biotechnology, Inc. | 2 | $33 |
| Jazz Pharmaceuticals Inc. | 2 | $31 |
| Merck | 2 | $29 |
| Seagen Inc. | 2 | $29 |
| Incyte Corporation | 2 | $28 |
| Smith+Nephew | 1 | $27 |
| Kyowa Kirin, Inc. | 2 | $26 |
| Convatec Inc. | 1 | $23 |
| Rigel Pharmaceuticals, Inc. | 1 | $20 |
| Karyopharm Therapeutics Inc. | 1 | $18 |
| Foundation Medicine, Inc. | 1 | $16 |
| Novocure Inc. | 1 | $15 |
| Lilly USA, LLC | 1 | $14 |
| Bayer | 1 | $13 |
| Daiichi Sankyo Inc. | 1 | $12 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,044 in reported general payments places this provider in the 85th percentile of 319 acute care providers in Kentucky.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 13 | $182 |
| Lorazepam | 12 | $161 |
| Gabapentin | 21 | $121 |
| Pregabalin | 12 | $116 |
| Ciprofloxacin Hcl | 11 | $114 |
Paid to pharmacies, not to this prescriber.
Other acute care in Bardstown
- Shannon AtkinsonBowling Green$63K
- Billie WaltersLexington$20K
- Audra MarcumLexington$14K
- Holly ChitwoodLexington$10K
- Vanessa PaddyElizabethtown$8K
- Baylee KnoxGlasgow$8K
- Katherine BeanOwensboro$7K
- Anna BayesAshland$7K
- Brittany ShortAshland$6K
- Chadwick HuntLexington$6K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.